MR1 and cancer: Notably, the MOC‐L1‐sh‐mR1#1 and MOC‐L1‐sh‐mR1#2 cells exhibited remarkable cancer regression compared with MOC‐L1‐sh‐Ctrl cells (Figure 4A).